Top Markets
#1 EXOD EXOD +56.80%
#2 CoW Protocol CoW Protocol +55.52%
#3 Glidr Glidr +38.71%
#4 Cysic Cysic +28.33%
#5 Walrus Walrus +25.77%
#6 Humanity Humanity +25.08%
#7 Enso Enso +18.12%
#8 Velvet Velvet +16.00%
#9 Tutorial Tutorial +15.35%
#10 OVERTAKE OVERTAKE +15.31%
Coin of the day
EXOD EXOD
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Quantum Genomics S.A. Quantum Genomics S.A.

Quantum Genomics S.A.

ALQGC
Classificação em ações #37063
Quantum Genomics S.A., a biopharmaceutical firm established in Paris, France,... Quantum Genomics S.A., a biopharmaceutical firm established in Paris, France, in 2005, focuses on creating treatments for cardiovascular ailments. Its therapeutic approach utilizes the brain aminopeptidase A inhibition (BAPAI) platform, primarily addressing high blood pressure (hypertension) and heart failure. The company's key asset, firibastat, is currently undergoing a crucial Phase III study as a standalone therapy for hypertension and is also in clinical trials for heart failure. Additionally, Quantum Genomics is progressing QGC011 for hypertension in combination therapy, and further developing QGC006 and QGC606 to target both hypertension and heart failure.
Preço da ação
$0.07600875
Última sincronização: 2024-11-20
Valor de mercado
$2.06M
Variação (1 dia)
-0.51%
Variação (1 ano)
0.00%
País
FR
Negociar Quantum Genomics S.A. (ALQGC)

Categoria

Healthcare
Rácio P/B de Quantum Genomics S.A. (ALQGC)
Rácio P/B em August 2026 TTM: -2.05
De acordo com os relatórios financeiros mais recentes e o preço das ações da Quantum Genomics S.A., o rácio P/B atual (TTM) é -2.05. No final de 2023, o rácio P/B era 8.46.
Histórico do rácio P/B da Quantum Genomics S.A. de 2009 a 2026
Rácio P/B no final de cada ano
Ano Rácio P/B Alterar
2026 (TTM) -2.05 -0.18%
2024 -2.05 -124.18%
2023 8.46 649.27%
2022 1.13 -90.55%
2021 11.95 194.68%
2020 4.06 -37.21%
2019 6.46 -8.65%
2018 7.07 87.24%
2017 3.78 -35.35%
2016 5.84 -20.06%
2015 7.31 -103.58%
2014 -204.14 1,261.27%
2013 -15.00 -41.14%
2012 -25.48 74.82%
2011 -14.57 70.19%
2010 -8.56 -101.36%
2009 630.17 0.00%
Rácio P/B de empresas semelhantes ou concorrentes
Empresa Rácio P/B Diferença do rácio P/B País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -409.91%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -404.99%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.4612 -269.14%
BE